Preventive effect of IgG from EBV-seropositive donors on the development of human lympho-proliferative disease in SCID mice

International Journal of Cancer

Volumn 71, Issue 4, 1997, Pages 624-629

  Abedi, Mohammad R ^a   Linde, Annika ^b   Christensson, Birger ^a   Mackett, Mike ^c   Hammarström, Lennart ^a,d   Smith, C I Edvard ^a,d  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c CHRISTIE HOSPITAL   (United Kingdom)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; IMMUNOGLOBULIN G; RECOMBINANT ALPHA2B INTERFERON; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LYMPHOPROLIFERATIVE DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE;

ABDOMINAL NEOPLASMS; ANIMALS; ANTIBODIES, VIRAL; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; INTERFERON-ALPHA; LEUKOCYTES, MONONUCLEAR; LYMPHOMA, B-CELL; LYMPHOPROLIFERATIVE DISORDERS; MICE; MICE, SCID; RABBITS; SPECIFIC PATHOGEN-FREE ORGANISMS; TUMOR VIRUS INFECTIONS; VIRAL MATRIX PROTEINS;

EID: 0030965373     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970516)71:4<624::AID-IJC19>3.0.CO;2-B     Document Type: Article

References (29)

1. ABEDI, M.R., CHRISTENSSON, B., AL-MASUD, S., HAMMARSTRÖM., L. and SMITH, C.I.E., Gamma-globulin modulates growth of EBV-derived B-cell tumors in SCID mice reconstituted with human lymphocytes. Int. J. Cancer, 55, 824-829 (1993).
2. ABEDI, M.R., CHRISTENSSON, B., ISLAM, K.B., HAMMARSTRÖM, L. and SMITH, C.I.E., Immunoglobulin production in severe combined immunodeficient (SCID) mice reconstituted with human peripheral blood mononuclear cells. Europ. J. Immunol., 22, 823-828 (1992).
3. ÅMAN, P. and VON GABAIN, A., An Epstein-Barr virus immortalisation associated gene-segment interferes specially with the IFN-induced antiproliferative response in human B-lymphoid cell lines. EMBO J., 9, 147-152 (1990).
4. ERS, K.H., GUERRA, W.F., TOMIYASU, U., VERITY, M.A. and VINTERS, H. V., The neuropathology of AIDS. Amer. J. Pathol., 124, 537-558 (1986).
5. BARKHOLT, L.M., DAHL, H., ENBOM, M. and LINDE, A., Epstein-Barr virus DNA in serum after liver transplantation: surveillance of viral activity during treatment with different immunosuppressive agents. Transpl. Int., 9, 439-149 (1996).
6. BLUNT, T., FINNIE, N.J., TACCIOLI, G.E., SMITH, G.C., DEMENGEOT, J., GOTTLIEB, T.M., MIZUTA, R., VARGHESE, A.J., ALT, F.W., JEGGO, P.A. and JACKSON, S.P., Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation. Cell, 80, 813-823 (1995).
7. BOSMA, G.C., CUSTER, R.P. and BOSMA, M.J., A severe combined immunodeficiency mutation in the mouse. Nature (Lond.), 301, 527-530 (1983).
8. CINQUE, P., BRYTTING, M., VAGO, L., CASTAGNA, A., PARRAVICINI, C., ZANCHETTA, N., D'ARMINIO MONFORTE, A., WAHREN, B., LAZZARIN, A. and LINDE, A., Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet. 342, 398-401 (1993).
9. DURANDY, A., BROUSSE, N., ROZENBERG, F., DE SAINT BASILE, G., FISCHER, A.M. and FISCHER, A., Control of human B cell tumor growth in severe combined immunodeficiency mice by monoclonal anti-B cell antibodies. J. clin. Invest., 90, 945-952 (1992).
10. FALKSVEDEN, L.G. and LUNDBLAD, G., Ion exchange and polyethylene glycol precipitation of immunoglobulin G. In: J.M. Curlin (ed.). Methods of plasma protein fractionation, pp. 93-105, Academic Press, London (1980).
11. FENNEWALD, S., VAN SANTEN, V. and KIEFF, E., Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicated that it may encode a membrane protein. J. Virol., 51, 411-4-19 (1984).
12. FINERTY, S., TARLTON, J., MACKETT, M., CONWAY, M., ARRAND, J.R., WATKINS, P.E. and MORGAN, A.J., Protective immunization against Epstein-Barr virus-induced disease in cottontop tamarins using the virus envelope slycoprotein gp340 produced from a bovine papillomavirus expression vector. J. gen. Virol., 73, 449-153 (1992).
13. GHETIE, M.A., TUCKER, K., RICHARDSON, J., UHR, J.W. and VITETTA, E.S., The antitumor activity of an anti-CD22 immunotoxin in SCID mice with disseminated Daudi lymphoma is enhanced by either an anti-CD 19 antibody or an anti-CD 19 immunotoxin. Blood, 80, 2315-2320 (1992).
14. HAMIITON-DUTOIT, S.J., PALLESEN, G., KARKOV, J., SKINHOJ, P., FRANZMANN, M.B. and PEDERSEN, C., Identification of EBV-DNA in tumour cells of AIDS-related lymphomas by in-situ hybridization. Lancet, i, 554-555 (1989).
15. HANTO, D.W., FRIZZERA, G., GAJL-PECZALSKA, K.J. and SIMMONS, R.L., Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation, 39, 461-472 (1985).
16. HENDERSON, S., ROWE, M., GREGORY, C., CROOM-CARTER, D., WANG, F., LONGNECKER, R., KIEFF, E. and RICKINSON, A., Induction of Bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell, 65, 1107-1115 (1991).
17. HENNESSY, K., FENNEWALD, S., HUMMEL, M., COLE, T. and KIEFF, E., A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection. Proc. nat. Acad. Sci. (Wash.). 81, 7207-7211 (1984).
18. KIEFF, E. and LIEBOWITZ, D., Epstein-Barr virus and its replication. In: B. Fields and D. Knipe (eds.). Virology, pp. 1889-1920, Raven Press, New York (1990).
19. LINDE, A., ANDERSSON, J., LUNDGREN, G. and WAHREN. B., Subclass reactivity to Epstein-Barr virus capsid antigen in primary and reactivated EBV infections. J. med. Virol., 21, 109-121 (1987).
20. LINDE, A., KALLIN, B., DILLNER, J., ERSSON. J., LÄGDAHL, L., LINDVALL, A. and WAHREN. B., Evaluation of enzyme-linked immunosorbent assay with two synthetic peptides of Epstein-Barr virus for diagnosis of infectious mononucleosis. J. infect. Dis., 161, 903-909 (1990).
21. MADEJ, M., CONWAY, M.J., MORGAN. A.J., SWEET, J., WALLACE, L., QUALTIERE, L.F., ARRAND. J.R. and MACKETT, M., Purification and characterization of Epstein-Barr virus gp340/220 produced by a bovine papillomavirus expression vector system. Vaccine, 10, 777-782 (1992).
22. MILNER, A.E., GRAND, R.J.A. and GREGORY, C.D., Effect of interferon-α on human B cells: repression of apoptosis and prevention of cell growth are independent responses of Burkitt lymphoma lines. Int. J. Cancer, 61, 348-354 (1995).
23. MOSIER, D.E., GULIZIA, R.J., BAIRD, S.M. and WILSON, D.B., Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature (Lond.), 335, 256-259 (1988).
24. MOSIER, D.E., PICCHIO, G.R., BAIRD, S.M., KOBAYASHI, R. and KIPPS, T.J., Epstein-Barr virus-induced human B-cell lymphomas in SCID mice reconstituted with human peripheral blood leukocytes. Cancer Res., 52(Suppl.), 5552-5553 (1992).
25. MURRAY, R.J., KURILLA, M.G., BROOKS, J.M., THOMAS, W.A., ROW, M., KIEFF, E. and RICKINSON, A.B., Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. J. exp. Med., 176, 157-168 (1992).
26. OKANO. M., TAGUCHI, Y., NAKAMINE, H., PIRRUCCELLO, S.J., DAVIS, J.R., BEISEL, K.W., KLEVELAND, K.L., SANGER, W.G., FORDYCE, R.R. and PURTILO, D.T., Characterization of Epstein-Barr virus-induced lymphoproliferation derived from human peripheral blood monotuielear cells transferred to severe combined immunodeficient mice. Amer. J. Pathol., 137, 517-522 (1990).
27. PAPADOPOULOS, E.B., LADANYI, M., EMANUEL, D., MACKINNON, S., BOULAD, F., CARABASI, M.H., CASTRO-MALASPINA, H., CHILDS, B.H., GILLIO, A.P. SMALL, T.N., YOUNG, J.W., KERNAN, N.A. and O'REILLY, R.J., Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliterative disorders after alloeeneic bone marrow transplantation. N. Engl. J. Med., 330, 1185-1191 (1994).
28. THORLEY-LAWSON, D.A. and GEILINGER, K., Monoclonal antibodies aeainst the major glycoprotein (sp350/220) of Epstein-Barr virus neutralize infectivity. Proc. nat. Acad Sci. (Wash.). 77, 5307-5311 (1980).
29. VISCOMI, G.C., GRIMALDI, M., PALAZZINI, E. and SILVESTRI. S., Human leukocyte interferon alpha: structure, pharmacology, and therapeutic applications. Med. Res. Rev., 15, 445-478 (1995).